| 1 |
33655823 | Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents. | 2022 |
1 |
| 2 |
34524004 | Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. | 2022 May |
1 |
| 3 |
35451751 | SH2-Domain Protein Isolation Using Synthetic Phosphorylated Peptides to Study VEGFR2 Signaling. | 2022 |
3 |
| 4 |
32866228 | Preeclampsia and Increased Permeability Over the Blood-Brain Barrier: A Role of Vascular Endothelial Growth Receptor 2. | 2021 Feb 18 |
2 |
| 5 |
33554592 | Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases. | 2021 Mar 1 |
2 |
| 6 |
34742690 | PEDF is an endogenous inhibitor of VEGF-R2 angiogenesis signaling in endothelial cells. | 2021 Dec |
3 |
| 7 |
31642192 | Nuclear localization of the tyrosine kinase BMX mediates VEGFR2 expression. | 2020 Jan |
2 |
| 8 |
31935623 | Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values. | 2020 Jan 3 |
1 |
| 9 |
32044644 | Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs. | 2020 Mar |
1 |
| 10 |
32045054 | Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer. | 2020 Apr |
1 |
| 11 |
32053964 | Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles. | 2020 Feb 11 |
1 |
| 12 |
32055714 | Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor. | 2020 Mar |
1 |
| 13 |
30845793 | Protein Tyrosine Phosphatase, Receptor Type B (PTPRB) Inhibits Brown Adipocyte Differentiation through Regulation of VEGFR2 Phosphorylation. | 2019 Apr 28 |
1 |
| 14 |
31604823 | No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells. | 2019 Nov 29 |
1 |
| 15 |
31694662 | Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma. | 2019 Nov 6 |
2 |
| 16 |
31712231 | Tumour-bowel fistula as a possible complication of pazopanib therapy in retroperitoneal leiomyosarcoma. | 2019 Nov 10 |
1 |
| 17 |
31764847 | Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma. | 2019 Nov |
2 |
| 18 |
31787809 | Virtual screening,docking and molecular dynamics simulation of selected phytochemical compounds bound to receptor tyrosine kinases:A correlative anti angiogenic study. | 2019 |
1 |
| 19 |
31847469 | Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB. | 2019 Dec 15 |
2 |
| 20 |
32010646 | Metastatic Perivascular Epithelioid Cell Tumor Of The Kidney: A Case Report With Emphasis On Response To The Tyrosine-Kinase Inhibitor Sunitinib. | 2019 |
1 |
| 21 |
29964354 | Abstracts of the 68th annual meeting in University of Nottingham. | 2018 Jul 2 |
4 |
| 22 |
28330784 | Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas. | 2017 Jun |
2 |
| 23 |
28424170 | ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. | 2017 Jun 1 |
1 |
| 24 |
28817576 | Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1. | 2017 |
4 |
| 25 |
26993523 | Chronic high-magnitude cyclic stretch stimulates EC inflammatory response via VEGF receptor 2-dependent mechanism. | 2016 Jun 1 |
2 |
| 26 |
27266812 | Inhibition of vascular endothelial growth factor reduces cardiac allograft vasculopathy. | 2016 Sep |
1 |
| 27 |
27662093 | Evidence for Pro-angiogenic Functions of VEGF-Ax. | 2016 Sep 22 |
1 |
| 28 |
25102966 | VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction. | 2015 Feb |
2 |
| 29 |
25161153 | Emerging roles of post-translational modifications in signal transduction and angiogenesis. | 2015 Jan |
1 |
| 30 |
25354586 | Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. | 2015 Feb |
1 |
| 31 |
25698653 | Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling. | 2015 May |
1 |
| 32 |
25967108 | The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer. | 2015 May 13 |
1 |
| 33 |
25990504 | VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth. | 2015 May 20 |
2 |
| 34 |
26067165 | Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model. | 2015 Jun |
3 |
| 35 |
26327764 | Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. | 2015 Aug 28 |
1 |
| 36 |
26413215 | Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. | 2015 Jul |
1 |
| 37 |
24112971 | The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. | 2014 Jan |
1 |
| 38 |
24129914 | Recombinant human kallistatin inhibits angiogenesis by blocking VEGF signaling pathway. | 2014 Mar |
1 |
| 39 |
24508097 | Increased placental angiogenesis in late and early onset pre-eclampsia is associated with differential activation of vascular endothelial growth factor receptor 2. | 2014 Mar |
2 |
| 40 |
25237397 | Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis. | 2014 |
1 |
| 41 |
25657827 | The P2Y2 Receptor Interacts with VE-Cadherin and VEGF Receptor-2 to Regulate Rac1 Activity in Endothelial Cells. | 2014 Dec 1 |
1 |
| 42 |
23583373 | Early VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activity. | 2013 May 10 |
2 |
| 43 |
23636508 | The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates. | 2013 Sep |
1 |
| 44 |
22363548 | Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. | 2012 |
1 |
| 45 |
21316260 | Targeting phosphoinositide 3-kinase signalling in lung cancer. | 2011 Nov |
1 |
| 46 |
21402774 | PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. | 2011 May |
1 |
| 47 |
21752276 | Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. | 2011 Jul 13 |
2 |
| 48 |
21937443 | Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes. | 2011 Nov 18 |
1 |
| 49 |
22016776 | Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3. | 2011 |
1 |
| 50 |
22174934 | Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium. | 2011 |
1 |